- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the pharmacokinetics and incremental recovery of ReFacto AF in pediatric subjects less than 12 years of age after a single exposure to ReFacto AF.
Critère d'inclusion
- Severe hemophilia A (FVIII:C <1%) in male subjects <12 years of age